New_JJ
immunosuppressive_JJ
drug_NN
PNU156804_NN
blocks_VBZ
IL-2-dependent_JJ
proliferation_NN
and_CC
NF-kappa_NN
B_NN
and_CC
AP-1_NN
activation_NN
._.

We_PRP
had_VBD
previously_RB
shown_VBN
that_IN
the_DT
drug_NN
undecylprodigiosin_NN
-LRB-_-LRB-
UP_NN
-RRB-_-RRB-
blocks_VBZ
human_JJ
lymphocyte_NN
proliferation_NN
in_FW
vitro_FW
._.

We_PRP
have_VBP
now_RB
investigated_VBN
the_DT
mechanism_NN
of_IN
action_NN
of_IN
a_DT
new_JJ
analog_NN
of_IN
UP_NN
,_,
PNU156804_NN
,_,
which_WDT
shows_VBZ
a_DT
more_RBR
favorable_JJ
activity_NN
profile_NN
than_IN
UP_NN
in_IN
mice_NNS
._.

We_PRP
demonstrate_VBP
here_RB
that_IN
the_DT
biological_JJ
effect_NN
of_IN
PNU156804_NN
in_FW
vitro_FW
is_VBZ
indistinguishable_JJ
from_IN
UP_NN
:_:
PNU156804_NN
blocks_VBZ
human_JJ
T_NN
cell_NN
proliferation_NN
in_IN
mid-late_JJ
G1_NN
,_,
as_IN
determined_VBN
by_IN
cell_NN
cycle_NN
analysis_NN
,_,
expression_NN
of_IN
cyclins_NNS
,_,
and_CC
cyclin-dependent_JJ
kinases_NNS
and_CC
retinoblastoma_NN
phosphorylation_NN
._.

In_IN
addition_NN
,_,
we_PRP
show_VBP
that_IN
PNU156804_NN
does_VBZ
not_RB
block_VB
significantly_RB
the_DT
induction_NN
of_IN
either_CC
IL-2_NN
or_CC
IL-2R_NN
alpha_NN
-_:
and_CC
gamma-chains_NNS
but_CC
inhibits_VBZ
IL-2-dependent_JJ
T_NN
cell_NN
proliferation_NN
._.

We_PRP
have_VBP
investigated_VBN
several_JJ
molecular_JJ
pathways_NNS
that_WDT
are_VBP
known_VBN
to_TO
be_VB
activated_VBN
by_IN
IL-2_NN
in_IN
T_NN
cells_NNS
._.

We_PRP
show_VBP
that_IN
PNU156804_NN
does_VBZ
not_RB
inhibit_VB
c-myc_NN
and_CC
bcl-2_NN
mRNA_NN
induction_NN
._.

On_IN
the_DT
other_JJ
hand_NN
,_,
PNU156804_NN
efficiently_RB
inhibits_VBZ
the_DT
activation_NN
of_IN
the_DT
NF-kappa_NN
B_NN
and_CC
AP-1_NN
transcription_NN
factors_NNS
._.

PNU156804_NN
inhibition_NN
of_IN
NF-kappa_NN
B_NN
activation_NN
is_VBZ
due_JJ
to_TO
the_DT
inhibition_NN
of_IN
the_DT
degradation_NN
of_IN
I_NN
kappa_NN
B-alpha_NN
and_CC
I_NN
kappa_NN
B-beta_NN
._.

PNU156804_NN
action_NN
is_VBZ
restricted_JJ
to_TO
some_DT
signaling_VBG
pathways_NNS
;_:
it_PRP
does_VBZ
not_RB
affect_VB
NF-kappa_NN
B_NN
activation_NN
by_IN
PMA_NN
in_IN
T_NN
cells_NNS
but_CC
blocks_VBZ
that_IN
induced_VBN
by_IN
CD40_NN
cross-linking_NN
in_IN
B_NN
lymphocytes_NNS
._.

We_PRP
conclude_VBP
that_IN
the_DT
prodigiosin_NN
family_NN
of_IN
immunosuppressants_NNS
is_VBZ
a_DT
new_JJ
family_NN
of_IN
molecules_NNS
that_WDT
show_VBP
a_DT
novel_JJ
target_NN
specificity_NN
clearly_RB
distinct_JJ
from_IN
that_DT
of_IN
other_JJ
immunosuppressive_JJ
drugs_NNS
such_JJ
as_IN
cyclosporin_NN
A_NN
,_,
FK506_NN
,_,
and_CC
rapamycin_NN
._.

